On 5 October 2015, Life Science Developments Limited sold its copper project, changed its name and became a life science and biotech investment company and it also appointed Jim Mellon as a non-executive director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 GBX | 0.00% | +6.67% | -15.79% |
05-22 | Powerhouse resolves claim; PCI-PAL wins court case | AN |
05-20 | Bradda reaches settlement agreement over fraudulent payment | AN |
1st Jan change | Capi. | |
---|---|---|
-15.79% | 7.98M | |
+42.75% | 91.79B | |
+26.26% | 74.02B | |
-.--% | 28.73B | |
+63.04% | 10.58B | |
+17.65% | 9.54B | |
+23.27% | 9.11B | |
+2.61% | 7.91B | |
+38.47% | 6.47B | |
+22.33% | 5.08B |
- Stock Market
- Equities
- CDC Stock
- News Bradda Head Lithium Limited
- Life Science Developments Limited Appoints Jim Mellon as a Non-Executive Director